“The positive outlook revision is based on DRMC’s consistently robust operating margins and growing unrestricted reserves,” said S&P analyst Patrick Zagar. “Moreover, the hospital fully retired its variable rate series 2006 [certificates of participation] in March 2016, considerably improving debt metrics and debt service coverage.”
S&P also affirmed the “BBB-” rating on DRMC’s $27.7 million of series 2012 certificates of participation.
More articles on healthcare finance:
Craneware, OhioHealth to present on pharmacy revenue integrity HFMA’s Annual National Institute
NJ owes counties $37M in Medicaid repayments
Moody’s affirms Flagler Hospital’s ‘A3’ rating
